Evaluation of drainable volume measurements and their usage for predicting optimal cardiac support in patients supported by veno-arterial extracorporeal life support.
Recruiting
- Conditions
- cardiac failure10019280
- Registration Number
- NL-OMON40651
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Supported by veno-arterial extracorporeal life support (VA-ELS)
Signed informed consent
>18 years
Exclusion Criteria
Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Changes in drainable volume and changes in cardiac function.</p><br>
- Secondary Outcome Measures
Name Time Method <p>None.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie drainable volume's impact on hemodynamic stability in VA-ELS for acute cardiac failure?
How does drainable volume measurement compare to echocardiography in predicting VA-ELS weaning success in post-cardiac surgery patients?
Which biomarkers correlate with optimal drainable volume thresholds for VA-ELS efficacy in ischemic cardiomyopathy?
What adverse events are associated with VA-ELS drainable volume mismanagement and how are they mitigated in clinical practice?
Are there combination therapies with VA-ELS that enhance cardiac recovery based on drainable volume metrics in Medisch Universitair Ziekenhuis Maastricht trials?